Testing Marigold Gel Against Clindamycin Gel to Treat Pittaj Yonivyapad (Bacterial Vaginosis) in Women.

Evaluation Of Compartive Efficacy Of Marigold ( Tagetes erecta L.) Vaginal Gel Versus Clindamycin Vaginal Gel In Treatment Of Pittaj Yonivyapad (Bacterial Vaginosis)-A Randomized Controlled Trial. - Nil

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/10/095525

Enrollment

Registered

2025-10-01

Start date

Unknown

Completion date

Unknown

Last updated

2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N74- Female pelvic inflammatory disorders in diseases classified elsewhere

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients willing to give written consent to participation in research work. Diagnosed patients of pittaj yonivyapad (bacterial vaginosis). Between the age of 18 to 45 years and married irrespective of caste religion and socioeconomic background.

Exclusion criteria

Exclusion criteria: Pregnancy, PNC mother, menstruating women, menopausal women. Patient diagnosed with PID, pyrexia, diabetes, HIV, and VDRL. Use of antibiotics or antifungal agents in the past 14 days. Known allergy to marigold.

Design outcomes

Primary

Measure	Time frame
To assess the Efficacy Of Marigold (Tagetes erecta L.) Vaginal Gel Versus Clindamycin Vaginal Gel In Treatment Of Pittaj Yonivyapad (Bacterial Vaginosis)Timepoint: 0th day 5th day 7th day	—

Secondary

Measure	Time frame
To assess the Efficacy Of Marigold (Tagetes erecta L.) Vaginal Gel Versus Clindamycin Vaginal Gel In Treatment Of Pittaj Yonivyapad (Bacterial Vaginosis)Timepoint: 0th day 5th day 7th day	—

Countries

India

Contacts

Public ContactDR MITALI DABHADE

MAHATMA GANDHI AYURVED COLLEGE HOSPITAL AND RESEARCH CENTER SALOD WARDHA

dr.shilpajamdade@gmail.com9769493806

Outcome results